Dextromoramide
Above: molecular structure of dextromoramide.
Below: 3D representation of a dextromoramide molecule. | |
| Clinical data | |
|---|---|
| Trade names | Palfium |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy category |
|
| Routes of administration | Oral, Rectal, Intravenous, Insufflation |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | >75% |
| Protein binding | High |
| Metabolism | Liver, partly mediated by CYP3A4 |
| Elimination half-life | 3.5 hours |
| Excretion | Urine, faeces |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.013 |
| Chemical and physical data | |
| Formula | C25H32N2O2 |
| Molar mass | 392.543 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Dextromoramide (Palfium, Palphium, Jetrium, Dimorlin) is a powerful opioid analgesic approximately three times more potent than morphine but shorter acting. It is subject to drug prohibition regimes, both internationally through UN treaties and by the criminal law of individual nations, and is usually prescribed only in the Netherlands.